300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Social Impact
Email
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Social
Theatre
Climate
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Fashion
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
China
Cameroon
Guernsey
Colombia
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Guatemala
Sri Lanka
Switzerland
Jamaica
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
El Salvador
Sierra Leone
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Barbados
Belgium
Cyprus
Jordan
Ethiopia
Austria
Azerbaijan
Faroe Islands
Bulgaria
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Bahamas
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
Ukraine
San Marino
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Hil-Invent

VC Fund

Hil-Invent is a VC fund focused on Health Care and Medical. Hil-Invent operates as an investment firm.

Total investments:
5
Last investment:
Lead investor:
20%

Last updated:

Industries Hil-Invent invests in

Health CareMedicalWellnessTherapeuticsMedical Device

Stages Hil-Invent invests in

SeedSeries BSeries CFunding Round

Countries Hil-Invent invests in

FranceGermany

Investment Focus

Industry

  • Health Care 2 (40%)
  • Medical 1 (20%)
  • Wellness 1 (20%)
  • Therapeutics 1 (20%)
  • Medical Device 1 (20%)

Stage

  • Seed 1 (20%)
  • Series B 1 (20%)
  • Series C 1 (20%)
  • Funding Round 1 (20%)

Country

  • France 1 (20%)
  • Germany 1 (20%)

Investments

CompanyDescriptionRoundLinks
Captain T Cell Captain T Cell
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates. $23.2M / Nov 17, 2025
UroMems UroMems
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. $47.1M / Series C / Jun 25, 2024
Captain T Cell Captain T Cell
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates. $9.2M / Seed / May 22, 2024
UroMems UroMems
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. $8.3M / Series B / Apr 06, 2021
UroMems UroMems
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. $17.6M / Series B / May 20, 2020

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Social Impact
Email
Artificial Intelligence
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Sports
Education
Wellness
Automotive
Biotechnology
eSports
Legal
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Social
Theatre
Climate
LGBT
Cannabis
Infrastructure
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Fashion
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
China
Cameroon
Guernsey
Colombia
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Guatemala
Sri Lanka
Switzerland
Jamaica
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
El Salvador
Sierra Leone
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Angola
Barbados
Belgium
Cyprus
Jordan
Ethiopia
Austria
Azerbaijan
Faroe Islands
Bulgaria
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Bahamas
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
Ukraine
San Marino
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Hil-Invent invest in?

Hil-Invent invests primarily in Health Care, Medical and Wellness startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Hil-Invent last invest?

The most recent investment recorded for Hil-Invent closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Hil-Invent Find emails